Literature DB >> 16926651

Quality of life and health status in interstitial lung diseases.

Jolanda De Vries1, Marjolein Drent.   

Abstract

PURPOSE OF REVIEW: The aim of this review is to provide information on the influence of interstitial lung disease on patients' health status and quality of life, with an emphasis on which aspects might be affected by interstitial lung disease. RECENT
FINDINGS: The quality of life of sarcoidosis patients with current symptoms and patients with idiopathic pulmonary fibrosis is mainly impaired in the domains of physical health and level of independence. Concerning health status, sarcoidosis patients report reduced physical functioning, especially when they have current symptoms. The health status of idiopathic pulmonary fibrosis patients is impaired in almost all aspects. Subjectively assessed dyspnea is related to health status. A relationship between treatment and health status has not been found.
SUMMARY: Results from the existing studies show that both illnesses have a substantial impact on patients' life. Studies aiming at measuring quality of life or health status in other interstitial lung diseases are scarce or nonexistent.

Entities:  

Mesh:

Year:  2006        PMID: 16926651     DOI: 10.1097/01.mcp.0000239553.93443.d8

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  13 in total

Review 1.  End-of-life considerations in older patients who have lung disease.

Authors:  Renee D Stapleton; J Randall Curtis
Journal:  Clin Chest Med       Date:  2007-12       Impact factor: 2.878

2.  A comparison of health-related quality of life in idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.

Authors:  Molly Lubin; Hubert Chen; Brett Elicker; Kirk D Jones; Harold R Collard; Joyce S Lee
Journal:  Chest       Date:  2014-06       Impact factor: 9.410

3.  Does nebulized fentanyl relieve dyspnea during exercise in healthy man?

Authors:  Houssam G Kotrach; Jean Bourbeau; Dennis Jensen
Journal:  J Appl Physiol (1985)       Date:  2015-03-12

4.  Sleep disorders and health-related quality of life in patients with interstitial lung disease.

Authors:  Maria Mavroudi; Despoina Papakosta; Theodore Kontakiotis; Kaliopi Domvri; George Kalamaras; Vasiliki Zarogoulidou; Paul Zarogoulidis; Paschalina Latka; Haidong Huang; Wolfgang Hohenforst-Schmidt; Konstantinos Zarogoulidis
Journal:  Sleep Breath       Date:  2017-10-16       Impact factor: 2.816

5.  Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany.

Authors:  Matthias Griese; Melanie Haug; Frank Brasch; Achim Freihorst; Peter Lohse; Rüdiger von Kries; Theodor Zimmermann; Dominik Hartl
Journal:  Orphanet J Rare Dis       Date:  2009-12-12       Impact factor: 4.123

6.  A conceptual model of health-related quality of life in sarcoidosis.

Authors:  David E Victorson; David Cella; Heidi Grund; Marc A Judson
Journal:  Qual Life Res       Date:  2013-05-26       Impact factor: 4.147

7.  Quality of life assessment in interstitial lung diseases:a comparison of the disease-specific K-BILD with the generic EQ-5D-5L.

Authors:  Boglárka Lilla Szentes; Michael Kreuter; Thomas Bahmer; Surinder S Birring; Martin Claussen; Julia Waelscher; Reiner Leidl; Larissa Schwarzkopf
Journal:  Respir Res       Date:  2018-05-25

8.  Reliability and validity of Chinese version of a tool to assess the quality of life in idiopathic pulmonary fibrosis in patients with interstitial lung disease.

Authors:  Rui-Li Pan; Jeffrey J Swigris; Yan-Wei Zhao; Ai-Min Guo; Qing Wu; Si-Jia Li
Journal:  Int J Nurs Sci       Date:  2018-11-21

9.  Skeletal muscle oxygenation and regional blood volume during incremental limb loading in interstitial lung disease.

Authors:  Lisa Wickerson; Sunita Mathur; Dina Brooks; L V Bonetti; Lianne G Singer; John Granton; W Darlene Reid
Journal:  ERJ Open Res       Date:  2020-01-27

10.  Effects of pulmonary rehabilitation on daily life physical activity of fibrotic idiopathic interstitial pneumonia patients.

Authors:  Benoit Wallaert; Nicolas Masson; Olivier Le Rouzic; Baptiste Chéhère; Lidwine Wémeau-Stervinou; Jean-Marie Grosbois
Journal:  ERJ Open Res       Date:  2018-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.